# A Study to Learn About the Safety of TALZENNA in People With Prostate Cancer.

> **NCT06733337** · — · ACTIVE_NOT_RECRUITING · sponsor: **Pfizer** · enrollment: 1 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06733337
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-07-11
- **Primary completion:** 2029-06-22
- **Final completion:** 2029-06-22
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06733337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06733337, "A Study to Learn About the Safety of TALZENNA in People With Prostate Cancer.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06733337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*